期刊文献+

抗磷脂综合征的肾损害 被引量:12

Renal involvement associated with antiphospholipid syndrome
原文传递
导出
摘要 目的分析抗磷脂综合征(APS)致肾损害的临床特点,旨在提高对该类疾病的认识。方法回顾性分析北京协和医院1983年至2004年期间91例APS中肾损害的临床特点及其中8例的肾组织学表现。结果原发性APS(PAPS)13例(14.3%);继发性APS(SAPS)78例(85.7%),其中系统性红斑狼疮(SLE)55例(占SAPS的70.5%)。APS伴肾损害共82例(90.1%),男性20例、女性62例;PAPS肾损害发生率为76.9%,SAPS为92.3%;发生肾损害时年龄为(38±14)岁,肾损害前病程为(4.9±6.8)年。肾损害临床表现主要为蛋白尿(92.7%)、肉眼血尿(2.4%)、镜下血尿(76.8%)、高血压(33.0%)、肾功能不全(18.3%),其中12.2%为肾病综合征。14例(15.4%)出现急性肾功能不全,病因包括血栓性微血管病、肾动脉栓塞、肾静脉血栓形成等。肾组织学检查8例,均为SLE所致PAPS,APS肾病占62.5%,表现为肾小血管、肾小球毛细血管血栓形成以及肾小叶间动脉内膜增生、洋葱皮样改变。结论APS肾损害比较常见,临床上以蛋白尿最为多见,可伴血尿、高血压,可引起血栓性微血管病、肾动脉栓塞或肾静脉血栓形成,致肾功能急剧恶化。 Objective To analyze the clinical characteristics of renal involvement associated with antiphospholipid syndrome (APS). Methods Data of 91 cases with APS who were admitted to our hospital from 1983 to 2004 were reviewed. Results Thirteen cases (14.3%) were primary APS (PAPS) and 78 cases (85.7%) were secondary APS(SAPS) including 55 cases with systemic lupus erythematosus. Renal involvement were found in 82 APS cases (90.1%). 76.9% patients with PAPS and 92.3% with SAPS had renal involvement. The average age of renal involvement was (38±14) years old. The ratio of male to female was 1:3.1 and the period of pre-renal damage was (4.9 ±6.8) years. The clinical manifestations included proteinuria (92.7%), gross hematuria (2.4%), microscopic hematuria (76.8%), hypertension (33.0%) and renal insufficiency(18.3%). Fourteen cases (15.4%)of acute renal insufficiency were caused by thrombotic microangiopathy, renal artery thrombosis, renal vein thrombosis and others. Kidney biopsy specimens were obtained from 8 patients with SLE,among them,5 (62.5%)had APS nephropathy and exhibited thrombosis of renal capillaries and renal small vessels, and fibrous intimal hyperplasia of renal interlobular arteries. Onion-peeled renal interlobular arteries were also found. Concolusions Renal involvements in APS are quite common, mainly including proteinuria, hematuria and hypertension. Thrombotic microangiopathy, renal artery thrombosis, renal vein thrombosis may occur and progress to acute renal insufficiency.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2005年第6期320-323,共4页 Chinese Journal of Nephrology
  • 相关文献

参考文献9

  • 1Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum, 1999, 42:1309-1311.
  • 2Asherson RA, Cervera R. ‘Primary', ‘secondary' and other variants of the antiphospholipid syndrome. Lupus, 1994, 3:293-298.
  • 3冷晓梅,刘晓敏,艾脉兴,曾小峰,唐福林.抗磷脂综合征61例临床分析[J].中华医学杂志,2004,84(16):1367-1370. 被引量:18
  • 4Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome:clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum, 2002, 46: 1019-1027.
  • 5Boura P, Tselios K, Skendros P, et al. Antiphospholipid syndrome in Greece: clinical and immunological study and review of the literature. Angiology, 2004, 55:421-430.
  • 6Daugas E, Nochy D, Huong du LT, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol, 2002, 13:42-52.
  • 7Sangle SR, D'Cruz DP. Renal artery stenosis: a new facet of the antiphospholipid (Hughes) syndrome. Lupus, 2003, 12:803-804.
  • 8Nochy D, Daugas E, Droz D, et al. The intrarenal vascular involvement associated with primary antiphospholipid syndrome.J Am Soc Nephrol, 1999, 10:507-518.
  • 9Korkmaz C, Kabukcuoglu S, Isiksoy S, et al. Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy. Lupus, 2003, 12:760-765.

二级参考文献10

  • 1王元,顾懿,周烈,陈顺乐.SLE患者抗磷脂抗体纵行观察的初步分析[J].上海医学,1994,17(9):504-507. 被引量:5
  • 2Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome,clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum, 2002, 46:1019-1027.
  • 3Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med, 1994, 96: 3-9.
  • 4Avcin T, Cimas R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations.Lupus, 2002, 11: 4-10.
  • 5Durrani OM, Gordon C, Murray PI. Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol,2002,47: 215-238.
  • 6Rai R, Cohen H, Dave M, et al. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. BMJ, 1997,314: 253-257.
  • 7Juanola X, Mateo L, Domenech P, et al. Prevalence of antiphospholipid antibodies in patients with ankylosing spondylitis. J Rheumatol, 1995, 22:1891-1893.
  • 8Deleze M, Alarcon-Segnvia D, Oria CM, et al. Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol, 1989, 16: 926-930.
  • 9Cuadrado MJ, Mujic F, Munoz E, et al. Thrombocytopenia in the antiphospholipid syndrome. Ann Rheum Dis, 1997, 56:194-196.
  • 10Triolo G, Ferrante A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum, 2003

共引文献17

同被引文献124

  • 1肖慧捷,杨霁云,高天霁,黄建萍,姚勇,张焱.儿童抗磷脂抗体阳性13例报告[J].中华儿科杂志,2004,42(8):571-573. 被引量:5
  • 2鲍春德,陈晓翔.抗磷脂综合征诊治进展[J].医师进修杂志,2004,27(12):4-7. 被引量:16
  • 3Asherson RA, Cervera R, Piette JC, et al. The antiphospholipid syndrome Ⅱ :autoimmune thrombosis. Tetherlands Elsevier, 2002, Section Ⅱ :123-137.
  • 4Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol, 1999, 10: 507-518.
  • 5Tektonidou MG, Sotsiou F, Nakopoulou L, et al. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence,clinical associations, and long-term outcome. Arthritis Rheum, 2004, 50: 2569-2579.
  • 6Daugas E, Nochy D, du Huong LT, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol, 2002, 13: 42-52.
  • 7Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun, 2000, 15: 145-151.
  • 8Mok MY, Chan EY, Fong DY, et al. Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus. J Rheumatol, 2005, 32: 622-628.
  • 9Kozlovskaia NL, Shilov EM, Meteleva NA, et al. Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome. Ter Arkh, 2006, 78: 21-31.
  • 10Sangle S, D'Cruz D, Khamashta M, et al. Prevalence of hypertension in 600 patients with antiphospholipid syndrome. Rheumatology (Oxford), 2004, 43: 105.

引证文献12

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部